Abstract
Purpose
We investigated the factors promoting prescribing omissions (medication underuse) in long-term medical care and the impact of withholding indicated medications on quality of life.
Methods
In a population-based cohort study of older ambulatory patients (ESTHER), we collected data with sequential questionnaires from participants and from their GPs. Concurrently, in two consecutive home visits, trained study physicians performed comprehensive geriatric assessments and recorded all medicines currently taken. Each patient’s medication was screened for underuse using the START-2 criteria.
Results
Medication underuse (absence of ≥1 indicated medication) was present in 70.3 and 73.2 % of 989 participants at two consecutive home visit assessments, respectively. Following variable selection accounting for subject-specific heterogeneity over time, multivariate results revealed that more drugs (odds ratio with 95 % confidence intervals: 0.83 [0.78;0.87] per drug) and better cognitive status (0.93 [0.87;0.99] per point on the MMSE scale) were preventive factors, while worse self-reported health status (1.33 [1.05;1.67] per point on an 5-point scale) and increasing frequency of GP consultations (1.07 [1.00;1.15] per visit within the preceding 3 months) were positively associated with medication underuse. An increase in omitted medications over time was associated with worse quality of life as determined on the EuroQuol EQ-Vas and EQ-5D scales.
Conclusion
In addition to general and physician-related factors, also patient-related aspects, such as individual health appraisal, were associated with medication underuse. Because withholding indicated drugs was associated with substantially reduced quality of life, controlled intervention studies are necessary to confirm the notion that pharmacological appropriateness improves personal wellbeing.
Similar content being viewed by others
References
Cherubini A, Corsonello A, Lattanzio F (2012) Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging 29(6):463–475. doi:10.2165/11631750-000000000-00000
Hanlon JT, Schmader KE, Ruby CM, Weinberger M (2001) Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 49(2):200–209
Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C, Hughes CM (2015) Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open 5(12):e009235. doi:10.1136/bmjopen-2015-009235
Nobili A, Franchi C, Pasina L, Tettamanti M, Baviera M, Monesi L, Roncaglioni C, Riva E, Lucca U, Bortolotti A, Fortino I, Merlino L (2011) Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiol Drug Saf 20(5):488–496. doi:10.1002/pds.2108
Lipton HL, Bero LA, Bird JA, McPhee SJ (1992) Undermedication among geriatric outpatients: results of a randomized controlled trial. Ann Rev Gerontol Ger 12:95–108
Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L (2011) Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 10(4):430–439. doi:10.1016/j.arr.2011.03.003
Nelson EA, Dannefer D (1992) Aged heterogeneity: fact or fiction? The fate of diversity in gerontological research. Gerontologist 32(1):17–23
Holmes HM, Hayley DC, Alexander GC, Sachs GA (2006) Reconsidering medication appropriateness for patients late in life. Arch Intern Med 166(6):605–609. doi:10.1001/archinte.166.6.605
Say RE, Thomson R (2003) The importance of patient preferences in treatment decisions—challenges for doctors. BMJ 327(7414):542–545. doi:10.1136/bmj.327.7414.542
van den Brink-Muinen A, van Dulmen SM, de Haes HC, Visser AP, Schellevis FG, Bensing JM (2006) Has patients’ involvement in the decision-making process changed over time? Health Expect 9(4):333–342. doi:10.1111/j.1369-7625.2006.00413.x
Barry PJ, Gallagher P, Ryan C, O’Mahony D (2007) START (screening tool to alert doctors to the right treatment)—an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 36(6):632–638. doi:10.1093/ageing/afm118
Gnjidic D, Le Couteur DG, Hilmer SN (2014) Discontinuing drug treatments. BMJ 349:g7013. doi:10.1136/bmj.g7013
van der Cammen TJ, Rajkumar C, Onder G, Sterke CS, Petrovic M (2014) Drug cessation in complex older adults: time for action. Age Ageing 43(1):20–25. doi:10.1093/ageing/aft166
Gallagher PF, O’Connor MN, O’Mahony D (2011) Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 89(6):845–854. doi:10.1038/clpt.2011.44
Ryan C, O’Mahony D, Kennedy J, Weedle P, Byrne S (2009) Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol 68(6):936–947. doi:10.1111/j.1365-2125.2009.03531.x
Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA, Group OS (2008) Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 65(1):130–133. doi:10.1111/j.0306-5251.2007.02961.x
Liu CL, Peng LN, Chen YT, Lin MH, Liu LK, Chen LK (2012) Potentially inappropriate prescribing (IP) for elderly medical inpatients in Taiwan: a hospital-based study. Arch Gerontol Geriatr 55(1):148–151. doi:10.1016/j.archger.2011.07.001
Galvin R, Moriarty F, Cousins G, Cahir C, Motterlini N, Bradley M, Hughes CM, Bennett K, Smith SM, Fahey T, Kenny RA (2014) Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA). Eur J Clin Pharmacol 70(5):599–606. doi:10.1007/s00228-014-1651-8
Moriarty F, Bennett K, Fahey T, Kenny RA, Cahir C (2015) Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people. Eur J Clin Pharmacol 71(4):473–482. doi:10.1007/s00228-015-1815-1
Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM (2015) Managing patients with multimorbidity in primary care. BMJ 350:h176. doi:10.1136/bmj.h176
McLean AJ, Le Couteur DG (2004) Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56(2):163–184. doi:10.1124/pr.56.2.4
Saum KU, Dieffenbach AK, Muller H, Holleczek B, Hauer K, Brenner H (2014) Frailty prevalence and 10-year survival in community-dwelling older adults: results from the ESTHER cohort study. Eur J Epidemiol 29(3):171–179. doi:10.1007/s10654-014-9891-6
Meid AD, Quinzler R, Freigofas J, Saum KU, Schottker B, Holleczek B, Heider D, Konig HH, Brenner H, Haefeli WE (2015) Medication underuse in aging outpatients with cardiovascular disease: prevalence, determinants, and outcomes in a prospective cohort study. PLoS one 10(8):e0136339. doi:10.1371/journal.pone.0136339
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213–218. doi:10.1093/ageing/afu145
Larrat EP, Taubman AH, Willey C (1990) Compliance-related problems in the ambulatory population. Am Pharm NS30(2):18–23
Dolan P (1997) Modeling valuations for EuroQol health states. Med Care 35(11):1095–1108
EuroQol G (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208
Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220–233
Wild B, Heider D, Maatouk I, Slaets J, Konig HH, Niehoff D, Saum KU, Brenner H, Sollner W, Herzog W (2014) Significance and costs of complex biopsychosocial health care needs in elderly people: results of a population-based study. Psychosom Med 76(7):497–502. doi:10.1097/PSY.0000000000000080
Linn BS, Linn MW, Gurel L (1968) Cumulative illness rating scale. J Am Geriatr Soc 16(5):622–626
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495. doi:10.1503/cmaj.050051
Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61–65
van Buuren S, Groothuis-Oudshoorn K (2011) mice: Multivariate imputation by chained equations in R. J Stat Softw 45(3):1–67
Groll A, Tutz G (2014) Variable selection for generalized linear mixed models by L1-penalized estimation. Stat Comput 24:137–154
Wood AM, White IR, Royston P (2008) How should variable selection be performed with multiply imputed data? Stat Med 27(17):3227–3246. doi:10.1002/sim.3177
Tibshirani R (1996) Regression shrinkage and selection via the lasso. J R Stat Soc Ser B Methodol 58(1):267–288. doi:10.2307/2346178
Turner H, Firth D (2012) Bradley-Terry Models in R: the BradleyTerry2 package. J Stat Softw 48(9):1–21
Hanlon JT, Wang X, Castle NG, Stone RA, Handler SM, Semla TP, Pugh MJ, Berlowitz DR, Dysken MW (2011) Potential underuse, overuse, and inappropriate use of antidepressants in older veteran nursing home residents. J Am Geriatr Soc 59(8):1412–1420. doi:10.1111/j.1532-5415.2011.03522.x
Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ (2006) Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 54(10):1516–1523. doi:10.1111/j.1532-5415.2006.00889.x
Olsson IN, Runnamo R, Engfeldt P (2011) Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes 9:95. doi:10.1186/1477-7525-9-95
Cahir C, Bennett K, Teljeur C, Fahey T (2014) Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol 77(1):201–210. doi:10.1111/bcp.12161
Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370(9582):173–184. doi:10.1016/S0140-6736(07)61091-5
Statistisches Bundesamt Deutschland (2008) Periodensterbetafeln für Deutschland https://www.destatis.de/DE/Publikationen/Thematisch/Bevoelkerung/Bevoelkerungsbewegung/PeriodensterbetafelErlaeuterung.html. Accessed 21 October 2015
Meid AD, Lampert A, Burnett A, Seidling HM, Haefeli WE (2015) The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis. Br J Clin Pharmacol 80(4):768–776. doi:10.1111/bcp.12657
Beyer M, Chenot R, Erler A, Gerlach FM (2011) Using quality indicators to measure the quality of general practice care in Germany. Z Evid Fortbild Qual Gesundhwes 105(1):13–20. doi:10.1016/j.zefq.2010.09.018
Hamilton HJ, Gallagher PF, O’Mahony D (2009) Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 9:5. doi:10.1186/1471-2318-9-5
Fleg JL, Aronow WS, Frishman WH (2011) Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol 8(1):13–28. doi:10.1038/nrcardio.2010.162
Gellad WF, Grenard JL, Marcum ZA (2011) A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 9(1):11–23. doi:10.1016/j.amjopharm.2011.02.004
Wu JY, Leung WY, Chang S, Lee B, Zee B, Tong PC, Chan JC (2006) Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 333(7567):522. doi:10.1136/bmj.38905.447118.2F
Acknowledgments
This work was supported in part by the German Federal Ministry of Education and Research (BMBF, Berlin, Germany) under Grant Numbers 01ET0717, 01ET1004B, and 01GY1320B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author’s contribution
AMD and WEH substantially contributed to conception, design, analysis, and interpretation of the data of the study as well as writing of the manuscript. AG substantially contributed to the analysis and interpretation of the data and the preparation of the manuscript and critically revised the manuscript. HB designed and led the ESTHER study from its beginning. WEH, HHK, and BW substantially contributed to conception of the ESTHER study and critically revised the manuscript. KUS, BS, BW, DH, and HB contributed to conception and conduct of the data collection and critically revised the manuscript. All authors had full access to study data and approved the final version before publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
ESM 1
(DOCX 389 kb)
Rights and permissions
About this article
Cite this article
Meid, A.D., Quinzler, R., Groll, A. et al. Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life. Eur J Clin Pharmacol 72, 877–885 (2016). https://doi.org/10.1007/s00228-016-2047-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-016-2047-8